Clinical Trials
Novartis provides update on RUXCOVID study of ruxolitinib for hospitalized patients with COVID-19
Novartis announced that the Phase III RUXCOVID study evaluating ruxolitinib on top of standard of care (SoC) therapy compared to SoC treatment alone in patients with COVID-19 did not meet its primary endpoint. Initial data show there was no...
News
Saudi Arabia approves Pfizer-BioNTech coronavirus vaccine
Saudi Arabia approved the use of the Pfizer-BioNTech novel coronavirus vaccine, state media reported, becoming the second Gulf country after Bahrain to green-light the drug.
"The Saudi Food and Drug Authority (SFDA) has approved the registration of Pfizer-BioNTech Covid-19 vaccine...
News
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
ERT, a global leader in clinical end-point data solutions, announced that Bioclinica, a technological and scientific leader in clinical imaging, has agreed to merge with ERT. This combination will create a leading partner to global pharmaceutical and biotechnology companies,...
Clinical Trials
Sinovac snags $515M investment to double COVID-19 vaccine capacity as phase 3 readout nears
As the various COVID-19 vaccines move closer to the finish line, their developers have been raising money from investors or through advance government purchases to ramp up manufacturing. Now, a Chinese company has done the same for its candidate.
Sinovac...
News
Sinovac Announces Product License for 23-Valent Pneumococcal Polysaccharide Vaccine
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that the China National Medical Products Administration (NMPA) has approved and issued a Product license for the Company’s 23-Valent Pneumococcal Polysaccharide (“PPV”) Vaccine to prevent the infection...
News
AstraZeneca and J&J COVID-19 Shots Crucial To Meet US Vaccination Goal
Moncef Slaoui from Operation Warp Speed suggests that AstraZeneca and Johnson & Johnson COVID-19 doses will play a significant role in vaccinating everyone in the US.
J&J candidate, being a one-shot vaccine will help in ramping up the...
News
Allergy Alarm Raised On Pfizer-BioNTech COVID-19 Vaccine
02 NHS Workers have reportedly suffered from allergic reactions from the first jab of Pfizer-BioNtech COVID-19 vaccine in the UK.
MHRA has issued an advisory asking people with an allergic history to refrain from vaccination.
An air of apprehension...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read